Race
Visit number vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Baseline | 316 | 267.5 | ± 139.5 | 279.8 | 0.0 | 607.3 | 2 | 318 |
Follow-up | 275 | 265.2 | ± 130.8 | 273.6 | 0.0 | 674.4 | 26 | 301 |
Treatment Arm vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 267.5 | ± 139.5 | 279.8 | 0.0 | 607.3 | 2 | 318 |
HLSE | 106 | 257.3 | ± 122.7 | 262.5 | 0.0 | 482.7 | - | 106 |
HLSE-O | 105 | 268.0 | ± 149.9 | 279.6 | 0.0 | 607.3 | 1 | 106 |
HLSE-P | 105 | 277.2 | ± 145.2 | 302.5 | 0.0 | 573.2 | 1 | 106 |
Treatment Arm vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 265.2 | ± 130.8 | 273.6 | 0.0 | 674.4 | 26 | 301 |
HLSE | 94 | 267.3 | ± 118.9 | 266.9 | 0.0 | 564.7 | 6 | 100 |
HLSE-O | 95 | 274.4 | ± 132.0 | 295.6 | 0.0 | 674.4 | 6 | 101 |
HLSE-P | 86 | 252.9 | ± 142.0 | 262.7 | 0.0 | 602.1 | 14 | 100 |
Age category vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 267.5 | ± 139.5 | 279.8 | 0.0 | 607.3 | 2 | 318 |
45-54 years | 52 | 275.9 | ± 131.3 | 279.4 | 0.0 | 573.2 | 1 | 53 |
55-64 years | 139 | 275.4 | ± 140.6 | 303.5 | 0.0 | 607.3 | - | 139 |
65 years or older | 125 | 255.2 | ± 141.8 | 248.0 | 0.0 | 547.8 | 1 | 126 |
Age category vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 265.2 | ± 130.8 | 273.6 | 0.0 | 674.4 | 25 | 300 |
45-54 years | 42 | 268.2 | ± 115.5 | 287.3 | 0.0 | 477.8 | 7 | 49 |
55-64 years | 117 | 278.2 | ± 140.1 | 285.6 | 0.0 | 674.4 | 10 | 127 |
65 years or older | 116 | 251.1 | ± 125.9 | 258.0 | 0.0 | 602.1 | 8 | 124 |
Gender vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 316 | 267.5 | ± 139.5 | 279.8 | 0.0 | 607.3 | 2 | 318 |
Female | 84 | 280.1 | ± 130.6 | 314.4 | 0.0 | 499.8 | - | 84 |
Male | 232 | 262.9 | ± 142.6 | 270.2 | 0.0 | 607.3 | 2 | 234 |
Gender vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 275 | 265.2 | ± 130.8 | 273.6 | 0.0 | 674.4 | 26 | 301 |
Female | 73 | 257.6 | ± 128.6 | 265.8 | 0.7 | 509.0 | 6 | 79 |
Male | 202 | 268.0 | ± 131.8 | 278.7 | 0.0 | 674.4 | 20 | 222 |
Race vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Baseline
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 311 | 269.0 | ± 138.8 | 281.1 | 0.0 | 607.3 | 2 | 313 |
White | 251 | 274.6 | ± 137.8 | 291.2 | 0.0 | 607.3 | 1 | 252 |
Black | 41 | 256.8 | ± 157.3 | 252.0 | 0.0 | 565.8 | 1 | 42 |
Other | 19 | 221.6 | ± 100.4 | 240.5 | 1.1 | 343.5 | - | 19 |
Race vs SpO2 Range/Position: 98-100% Cumulative Non-Supine
Follow-up
N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
---|---|---|---|---|---|---|---|---|
Total | 271 | 265.8 | ± 131.3 | 273.6 | 0.0 | 674.4 | 25 | 296 |
White | 219 | 270.4 | ± 131.5 | 274.9 | 0.0 | 674.4 | 18 | 237 |
Black | 34 | 249.9 | ± 135.2 | 277.0 | 0.0 | 507.0 | 6 | 40 |
Other | 18 | 239.3 | ± 122.8 | 230.8 | 43.6 | 602.1 | 1 | 19 |